[go: up one dir, main page]

ZA200907356B - Tapentadol for treating pain from arthritis - Google Patents

Tapentadol for treating pain from arthritis

Info

Publication number
ZA200907356B
ZA200907356B ZA200907356A ZA200907356A ZA200907356B ZA 200907356 B ZA200907356 B ZA 200907356B ZA 200907356 A ZA200907356 A ZA 200907356A ZA 200907356 A ZA200907356 A ZA 200907356A ZA 200907356 B ZA200907356 B ZA 200907356B
Authority
ZA
South Africa
Prior art keywords
tapentadol
arthritis
treating pain
pain
treating
Prior art date
Application number
ZA200907356A
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39500012&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200907356(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of ZA200907356B publication Critical patent/ZA200907356B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200907356A 2007-04-23 2009-10-20 Tapentadol for treating pain from arthritis ZA200907356B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007019417A DE102007019417A1 (de) 2007-04-23 2007-04-23 Tapentadol zur Schmerzbehandlung bei Arthrose

Publications (1)

Publication Number Publication Date
ZA200907356B true ZA200907356B (en) 2010-08-25

Family

ID=39500012

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907356A ZA200907356B (en) 2007-04-23 2009-10-20 Tapentadol for treating pain from arthritis

Country Status (22)

Country Link
US (3) US20090005458A1 (xx)
EP (3) EP2857013A1 (xx)
JP (1) JP5796959B2 (xx)
KR (4) KR20100017268A (xx)
CN (2) CN106619589A (xx)
AU (1) AU2008241012B2 (xx)
CA (1) CA2683779C (xx)
CY (1) CY1115975T1 (xx)
DE (1) DE102007019417A1 (xx)
DK (1) DK2148669T3 (xx)
ES (1) ES2528215T3 (xx)
HK (1) HK1203160A1 (xx)
HR (1) HRP20141234T1 (xx)
IL (1) IL201664A (xx)
MX (1) MX2009011346A (xx)
NZ (1) NZ580414A (xx)
PL (1) PL2148669T3 (xx)
PT (1) PT2148669E (xx)
RU (1) RU2473337C2 (xx)
SI (1) SI2148669T1 (xx)
WO (1) WO2008128739A1 (xx)
ZA (1) ZA200907356B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
ES2758831T3 (es) * 2008-10-30 2020-05-06 Gruenenthal Gmbh Nuevas y potentes formas de dosificación de tapentadol
BRPI0923213A2 (pt) * 2008-12-22 2016-01-26 Novaris Ag regime de dosagem de um agonista do receptor para s1p.
WO2010124856A1 (en) 2009-04-30 2010-11-04 Grünenthal GmbH Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
WO2011133178A1 (en) * 2010-04-21 2011-10-27 Pharmacofore, Inc Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
MX341072B (es) 2010-07-23 2016-08-05 Grünenthal Gmbh * Sales o co-cristales de 3-(3-dimetilamino-1-etil-2-metil-propil)-f enol.
UA114283C2 (uk) 2011-01-07 2017-05-25 Новартіс Аг Композиції імуносупресантів
CZ304576B6 (cs) * 2012-07-24 2014-07-16 Zentiva, K.S. Oxalát TAPENTADOLU a způsob jeho přípravy
WO2016135644A1 (en) 2015-02-26 2016-09-01 Novartis Ag Treatment of autoimmune disease in a patient receiving additionally a beta-blocker
WO2017085734A1 (en) 2015-11-17 2017-05-26 Msn Laboratories Private Limited Crystalline forms of tapentadol salts and process for preparation thereof
US11434200B2 (en) 2017-03-09 2022-09-06 Novartis Ag Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof
KR102733355B1 (ko) 2019-10-02 2024-11-25 주식회사 엘지에너지솔루션 병렬 연결 셀의 연결 고장 검출 방법 및 시스템
HUE059465T2 (hu) 2020-11-10 2022-11-28 Gruenenthal Gmbh A tapentadol L-(+)- borkõsav-só késleltetett felszabadulású adagolási formája

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716646A (en) * 1990-05-01 1998-02-10 Smith; Steven A. Methods and compositions for treating arthritis
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
US20050005870A1 (en) 2003-07-11 2005-01-13 The Clorox Company Composite absorbent particles
DE602004007905T2 (de) * 2004-06-28 2008-05-08 Grünenthal GmbH Kristalline Formen von (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochlorid
WO2007005716A2 (en) * 2005-06-30 2007-01-11 Cinergen, Llc Methods of treatment and compositions for use thereof

Also Published As

Publication number Publication date
WO2008128739A1 (de) 2008-10-30
HK1140939A1 (en) 2010-10-29
US20100331425A1 (en) 2010-12-30
AU2008241012A1 (en) 2008-10-30
CN106619589A (zh) 2017-05-10
US20090005458A1 (en) 2009-01-01
KR20150027307A (ko) 2015-03-11
CY1115975T1 (el) 2017-01-25
NZ580414A (en) 2012-03-30
US20120041071A1 (en) 2012-02-16
RU2009142937A (ru) 2011-05-27
JP2010524989A (ja) 2010-07-22
CN103298463A (zh) 2013-09-11
EP3673903A1 (de) 2020-07-01
HK1203160A1 (en) 2015-10-23
IL201664A0 (en) 2010-05-31
PL2148669T3 (pl) 2015-03-31
DE102007019417A1 (de) 2008-11-13
MX2009011346A (es) 2009-11-05
AU2008241012B2 (en) 2012-12-06
IL201664A (en) 2016-11-30
KR20190020849A (ko) 2019-03-04
CA2683779C (en) 2016-01-05
EP2857013A1 (de) 2015-04-08
HRP20141234T1 (hr) 2015-02-27
KR20100017268A (ko) 2010-02-16
RU2473337C2 (ru) 2013-01-27
EP2148669A1 (de) 2010-02-03
DK2148669T3 (en) 2015-01-05
PT2148669E (pt) 2015-02-03
JP5796959B2 (ja) 2015-10-21
ES2528215T3 (es) 2015-02-05
CA2683779A1 (en) 2008-10-30
EP2148669B1 (de) 2014-12-10
KR20170068608A (ko) 2017-06-19
SI2148669T1 (sl) 2015-01-30

Similar Documents

Publication Publication Date Title
ZA200907356B (en) Tapentadol for treating pain from arthritis
EP2124777A4 (en) DEVICES FOR SPINE COLUMN TREATMENT
GB2445465B (en) Process for waste treatment
ZA200809528B (en) Treatment for depressive disorders
GB0714363D0 (en) Treatment apparatus
EP2079414A4 (en) SYSTEM FOR CHEMOHYPER THERMAL TREATMENT
GB0606604D0 (en) Treatment apparatus
EP2195067A4 (en) BONE TREATMENT UNIT
ZA200809527B (en) Treatment for depressive disorders
IL201422A0 (en) Therapeutic agents useful for treating pain
GB0711342D0 (en) Well treatment
IL238394A0 (en) Cancer treatment method
GB2449996B (en) Effluent treatment process
PL2131841T3 (pl) Sposoby leczenia bólu ostrego
GB0718684D0 (en) Treatment method
EP2182884A4 (en) TREATMENT APPARATUS
GB0716784D0 (en) Well treatment
PL2424514T3 (pl) Tapentadol do leczenia bólu w reumatoidalnym zapaleniu stawów
ZA200904478B (en) Novel therapeutic use for treating leukaemia
GB0707556D0 (en) Treatment for cancer
PL2043792T3 (pl) System do obróbki ciągłej
GB2451349B (en) Epicondylitis treatment
ZA200903242B (en) Treatment for multiple myeloma
HK40035200A (en) Tapentadol for treating pain from arthritis
GB0705207D0 (en) Treatment for neuropathic pain